Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Saturday, October 24, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
X
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Venture Capital
Venture Capital
Venture Capital
Estuary Biotherapeutics Launches with $103 Million to Advance Gene Therapies for Kidney Disease
Life Sciences Times
-
October 16, 2026
Venture Capital
Acta Pharmaceuticals Raises $24 Million to Advance Alzheimer’s Disease Treatments
Life Sciences Times
-
October 15, 2026
Venture Capital
Soufflé Therapeutics Raises $135 Million in Series B Financing to Advance RNA Therapies
Life Sciences Times
-
October 13, 2026
Venture Capital
Consano Bio Raises More Than $15 Million to Advance Chronic Sciatica Therapy
Life Sciences Times
-
October 5, 2026
Venture Capital
ai3Bio Launches With $48 Million Series A to Advance Autoimmune Disease Therapies
Life Sciences Times
-
September 29, 2026
Venture Capital
Cerebras Systems Raises $250M in Funding for Over $4B Valuation to Advance the Future of Artificial Intelligence Compute
Life Sciences Times
-
November 10, 2021
0
Venture Capital
AVROBIO Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Life Sciences Times
-
November 5, 2021
0
Venture Capital
bit.bio Raises in Excess of $100 Million in First Close of Series B Financing
Life Sciences Times
-
November 5, 2021
0
Venture Capital
GlycoEra AG Raises CHF 45 Million (US$ 49 Million) Series A Financing to Develop Novel Biologics Based on Innovative Glycoengineering Platform
Life Sciences Times
-
November 5, 2021
0
Venture Capital
Thoma Bravo Completes Acquisition of QAD
Life Sciences Times
-
November 5, 2021
0
Venture Capital
GrafTech Announces $150 Million Share Repurchase Authorization
Life Sciences Times
-
November 4, 2021
0
Venture Capital
PlateletBio Completes $75.5M Series B Financing
Life Sciences Times
-
November 4, 2021
0
Venture Capital
Dalrada Corporation Investors Convert $6 Million Into Equity
Life Sciences Times
-
November 1, 2021
0
Venture Capital
Empowering Targeted Cancer Drug Discovery with AI and Novel Disease Models, Signet Therapeutics Raises ~$10 million in Seed-2 Round
Life Sciences Times
-
October 29, 2021
0
Venture Capital
Better Therapeutics Closes Business Combination and Debuts on Nasdaq
Life Sciences Times
-
October 29, 2021
0
Venture Capital
inTEST Expands Process Technology Offerings with Acquisition of Videology Imaging Solutions
Life Sciences Times
-
October 29, 2021
0
Venture Capital
Sphere Fluidics Closes a $40 Million Funding Round Led by Sofinnova Partners and Redmile Group
Life Sciences Times
-
October 28, 2021
0
1
...
94
95
96
...
115
Page 95 of 115
Most Read
Alnylam Reports Promising Phase 1b Results for Experimental Huntington’s Disease Treatment
October 23, 2026
Zai Lab Reports Promising Early Results for Experimental Small Cell Lung Cancer Treatment
October 23, 2026
Takeda Reports Improved Survival in Phase 3 Trial of Experimental Gastric Cancer Treatment
October 23, 2026
Convergent Therapeutics Reports Promising Phase 2 Results for Prostate Cancer Treatment
October 23, 2026